Current trends in pleurodesis

Current Opinion in Pulmonary Medicine

Volumn 3, Issue 4, 1997, Pages 319-325

  Rodriguez Panadero, Francisco ^a  

^a El Mirador   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

SCLEROSING AGENT; TALC;

HUMAN; PLEURA EFFUSION; PLEURODESIS; PNEUMOTHORAX; REVIEW;

HUMANS; PLEURAL EFFUSION; PLEURAL EFFUSION, MALIGNANT; PLEURODESIS; PNEUMOTHORAX; SCLEROSING SOLUTIONS; TALC;

EID: 0031183908     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-199707000-00015     Document Type: Article

References (65)

1. Light RW, Jenkinson SG, Minh V, George RB: Observation on pleural pressures as fluid is withdrawn during thoracentesis. Am Rev Respir Dis 1980, 121:799-804.
2. Segado A, Rodriguez-Panadero F, Martin J, Ayerbe R, Fernanden Guerra J, Valenzuela F: Trapped lung, pH and outcome of talc pleurodesis in malignant pleural effusions [abstract]. Eur Respir J 1994, 7(suppl 18):270S.
3. Rodriguez-Panadero F, Sanchez Gil R, Martin Juan J, Castillo Gomez J: Prediction of results of talc pleurodesis in malignant pleural effusions [abstract]. Am J Respir Crit Care Med 1994, 149,4:A1103.
4. Robinson RD, Fullerton DA, Albert JD, Sorensen J, Johnston MR: Use of pleural Tenckhoff catheter to palliate malignant pleural effusion. Ann Thorac Surg 1994, 57:286-288.
5. Petrou M, Kaplan D, Goldstraw P: Management of recurrent malignant pleural effusions. The complementary role of talc pleurodesis and pleuroperitoneal shunting. Cancer 1995, 75:801-805. The authors report their results in 180 patients who were referred to them for palliative treatment of recurrent malignant effusion. Sixty-three of these patients had a "trapped lung syndrome" and had a pleuroperitoneal shunt inserted, whereas thoracoscopic talc pleurodesis was done on the others. Effective palliation was achieved in more than 95% of the patients in each group.
6. Tzeng E, Ferguson MK: Predicting failure following shunting of pleural effusions. Chest 1990, 98:890-893.
7. Waller DA, Morritt GN, Forty J: Video-assisted thoracoscopic pleurectomy in the management of malignant pleural effusion. Chest 1995, 107:11454-11456.
8. Sanchez-Armengol A, Rodriguez-Panadero F: Survival and talc pleurodesis In metastatic pleural carcinoma, revisited. Report of 125 cases. Chest 1993, 104:1482-1485.
9. Sahn SA, Good JT Jr: Pleural fluid pH in malignant effusions. Diagnostic, prognostic and therapeutic implications. Ann Intern Med 1988, 108:345-349.
10. Almind M, Lange P, Viskum K: Spontaneous pneumothorax: comparison of simple drainage, talc pleurodesis, and tetracycline pleurodesis. Thorax 1989, 44:627-630.
11. Alfageme I, Moreno L, Huertas C, Vargas A, Hemandez J, Beiztegui A: Spontaneous pneumothorax. Long-term results with tetracycline pleurodesis. Chest 1994, 106:347-350.
12. Van de Brekel JA, Duurkens VAM, Vanderschueren RGJRA: Pneumothorax: results of thoracoscopy and pleurodesis with talc poudrage and thoracotomy. Chest 1993, 103:345-347.
13. Hausmann M, Keller R: Thoracoscopic pleurodesis in spontaneous pneumothorax. Schweiz Med Wochenschr 1994, 124:97-104.
14. Mouroux J, Elkaïm D, Padovani B, Myx A, Perrin C, Rotomondo C, Chavaillon JM, Blaive B, Richelme H: Video-assisted thoracoscopic treatment of spontaneous pneumothorax: technique and results of one hundred cases. J Thorac Cardiovasc Surg 1996, 112:385-391. This article describes the technique and results of video-assisted thoracoscopy in a consecutive series of 100 episodes of spontaneous pneumothorax in 97 patients. A 3% rate of recurrence of pneumothorax was observed, and complications were seen in 10% of the cases (no deaths occurred after surgery). Conversion to thoracotomy had to be done in five patients.
15. Liu H-P, Lin PJ, Hsieh M-J, Chang J-P, Chang C-H: Thoracoscopic surgery as a routine procedure for spontaneous pneumothorax: results from 82 patents. Chest 1995, 107:559-562.
16. Hurtgen M, Linder A, Friedel G, Toomes H: Video-assisted thoracoscopic pleurodesis. A survey conducted by the German Society for Thoracic Surgery. Thorac Cardiovasc Surg 1996, 44:199-203. This is a report on 1365 VATS procedures performed to treat pneumothorax in 19 German institutions. The overall rate of recurrence was 6.5%; no recurrences were seen when talc pleurodesis was used, and a high rate of recurrence (16.4%) was seen after attempts at fibrin-glue pleurodesis. When no pleurodesis procedure was added to thoracoscopic bleb resection, the overall recurrence rate was 10.2%.
17. Korner H, Andersen KS, Stangeland L, Ellingsen I, Engedal H: Surgical treatment of spontaneous pneumothorax by wedge resection without pleurodesis or pleurectomy. Eur J Cardiothorac Surg 1996, 10:656-659. In this series, the rate of recurrence was similar to that obtained using VATS combined with pleurodesis.
18. Naunheim KS, Mack MJ, Hazelrigg SR, Ferguson MK, Ferson FP, Boley TM, Landreneau RJ: Safety and efficacy of video-assisted thoracic surgical techniques for the treatment of spontaneous pneumothorax. J Thorac Cardiovasc Surg 1995, 109:1198-1204. The importance of looking for and treating small blebs is stressed with regard to the long-term results of VATS for pneumothorax.
19. Berger R: Pleurodesis for spontaneous pneumothorax. Will the procedure of choice please stand up? Chest 1994, 106:992-994.
20. Metersky ML, Colt HG, Olson LK, Shanks TG: AIDS-related spontaneous pneumothorax Risk factors and treatment Chest 1995, 108:946-951.
21. Wait MA, Dal Nogare AR: Treatment of AIDS-related spontaneous pneumothorax: a decade of experience. Chest 1994, 106:693-696.
22. Asboe D, Fisher M, Nelson MR, Kaplan DK, Al-Kattan K, Gazzard BG: Pneumothorax in AIDS: case reviews and proposed clinical management Genitourin Med 1996, 72:258-260.
23. Trachiotis GD, Vricella LA, Alyono D, Aaron BL, Hix WR: Management of AIDS-related pneumothorax. Ann Thorac Surg 1996, 62:1608-1613. After reviewing their experience with 36 patients who had AIDS-related pneumothorax, the authors advocate the use of a small-bore drainage or even a Heimlich-type valve (with outpatient management) in patients with advanced AIDS complicated by pneumothorax with bronchopleural fistula.
24. Noppen M, Dhondt E, Mahler T, Malfroot A, Dab I, Vincken W: Successful management of recurrent pneumothorax in cystic fibrosls by localized apical thoracoscopic talc poudrage. Chest 1994, 106:262-264.
25. Sudduth C, Sahn SA: Pleurodesis for nonmalignant pleural effusions: recommendations. Chest 1992, 102:1855-1860.
26. Vargas FS, Milanez JRC, Filomeno LTB, Fernandez A, Jatene A, Light RW: Intrapleural talc for the prevention of recurrence in benign or undiagnosed pleural effusions. Chest 1994, 106:1771-1775.
27. Nakamura A, Kojima Y, Ohmi H, Yamada J, Yamada Y: Peritoneal-pleural communications in hepatic hydrothorax demonstrated by thoracoscopy. Chest 1996, 109:579-581.
28. Mouroux J, Perrin C, Venissac N, Blaive B, Richelme H: Management of pleural effusion of cirrhotic origin. Chest 1996, 109:1093-1096. Interesting report on the treatment of effusions of cirrhotic origin with VATS, to close the peritoneopleural communications, and then talc pleurodesis.
29. Walker-Renard PB, Vaughan LM, Sahn SA: Chemical pleurodesis for malignant pleural effusions. Ann Intern Med 1994, 120:56-64.
30. Hurewitz AN, Lidonicci K, Wu CL, Reim D, Zucker S: Histologic changes of doxycycline pleurodesis in rabbits: effect of concentration and pH. Chest 1994, 106:1241-1245.
31. Herrington JD, Gora-Harper ML, Salley RK: Chemical pleurodesis with doxycycline 1 g. Pharmacotherapy 1996, 16:280-285.
32. Seaton KG, Patz EF Jr, Goodman PC: Palliative treatment of malignant pleural effusions: value of small-bore catheter thoracostomy and doxycycline sclerotherapy. Am J Roentgenol 1995, 164:589-591.
33. Knowles SR, Shapiro L, Shear NH: Serious adverse reactions induced by minocycline. Report of 13 patients and review of the literature. Arch Dermatol 1996, 132:934-939.
34. Light RW, Wang NS, Sassoon CSH, Gruer SE, Vargas FS: Comparison of the effectiveness of tetracycline and minocycline as pleural sclerosing agent in rabbits. Chest 1994, 106:577-582.
35. Vargas FS, Wang N-S, Lee HM, Gruer SE, Sassoon CSH, Light RW: Effectiveness of bleomycin in comparison to tetracycline as pleural sclerosing agent in rabbits. Chest 1993, 104:1582-1584.
36. Bjorkman S, Elisson LO, Gabrielsson J: Pharmacokinetics of quinacrine after intrapleural instillation in rabbits and man. J Pharm Pharmacol 1989, 41:160-163.
37. Wooten SA, Barbarash RA, Strange C, Sahn SA: Systemic absorption of tetracycline and lidocaine following intrapleural instillation. Chest 1988, 94:960-963.
38. Foresti V: Intrapleural Corynebacterium parvum for recurrent malignant pleural effusions. Respiration 1995, 62:21-26.
39. Ostrowsky MJ, Priesstman TJ, Houston RF, Martin WM: A randomized trial of intracavitary bleomycin and Corynebacterium parvum in the control of malignant pleural effusions. Radiother Oncol 1989, 14:19-26.
40. Vargas FS, Wang NS, Teixeira LR, Carmo AO, Silva LMMF, Light RW: Corynebacterium parvum versus tetracycline as pleural sclerosing agents in rabbits. Eur Respir J 1995, 8:2174-2177.
41. Bethune N: Pleural poudrage: a new technique for the deliberate production of pleural adhesions as a preliminary to lobectomy. J Thorac Surg 1935, 4:251-261.
42. Kennedy L, Sahn SA: Talc pleurodesis for the treatment of pneumothorax and pleural effusion. Chest 1994, 106:1215-1222.
43. Aelony Y, Boulin C: Local anesthesia with thoracoscopic talc poudrage pleurodesis [letter]. Chest 1996, 110:1126.
44. Rodriguez-Panadero F: Talc pleurodesis for treating malignant pleural effusions. Chest 1995, 108:1178-1179.
45. Viallet JR, Rey F, Astoul P, Boulin C: Thoracoscopic talc poudrage pleurodesis for malignant effusions: a review of 360 cases. Chest 1996, 110:1387-1393. Report on the effectiveness of and rate of complications associated with thoracoscopic talc poudrage done on 88 patients with malignant mesothelioma and 272 patients with metastatic pleural effusion. The rate of successful pleurodesis was 90.2% at 1 month and 82.1% for the lifelong follow-up. Adverse effects included one death, which occurred 3 days after the procedure in a patient with end-stage disease; fever in 9.8% of cases; empyema in 2.5% of cases; pulmonary infection in 0.8% of cases; and neoplastic invasion of the thoracoscopic scar in one patient. The authors conclude that thoracoscopic talc pleurodesis should be done early in the management of patients with malignant effusion to prevent respiratory failure associated with the poor condition of the patient at the time the procedure is done.
46. Cohen RG, Shely WW, Thompson SE, Hagen JA, Marboe CC, DeMeester TR, Starnes VA: Talc pleurodesis: talc slurry versus thoracoscopic talc insufflation in a porcine model. Ann Thorac Surg 1996, 62:1000-1004. In 11 immature pigs, talc slurry pleurodesis was performed on one hemithorax and thoracoscopic talc pleurodesis was done on the other. Results of gross and microscopic examinations are detailed, and the authors conclude that effective pleurodesis can be obtained with either talc slurry or thoracoscopic talc insufflation in this model.
47. Yim AP, Chan AT, Lee TW, Wan IY, Ho JK: Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion. Ann Thorac Surg 1996, 62:1655-1658. From a randomized study that included 57 patients with malignant pleural effusion, these authors conclude that video-assisted thoracoscopic talc insufflation was not significantly superior to talc slurry for the outcome of pleurodesis.
48. Aelony Y: Talc pleurodesis: talc slurry vs talc poudrage. Chest 1995, 108:289.
49. Light RW, Wang N-S, Sassoon CSH, Gruer SE, Vargas FS: Talc slurry is an effective pleural sclerosant in rabbits. Chest 1995, 107:1702-1706.
50. Villanueva AG, Gray AW Jr, Shahian DM, Williamson WA, Beamis JF Jr: Efficacy of short term versus long term tube thoracostomy drainage before tetracycline pleurodesis in the treatment of malignant pleural effusions. Thorax 1994, 49:23-25.
51. Dryzer SR, Allen ML, Strange C, Sahn SA: Rotational maneuvers do not improve success in chemical pleurodesis [abstract]. Am Rev Respir Dis 1993, 147:A796.
52. Rozenman J, Yellin A, Simansky DA, Shiner RJ: Re-expansion pulmonary edema following spontaneous pneumothorax. Respir Med 1996, 90:235-238.
53. Mahfood S, Hix WR, Aaron BL, Blaes P, Watson DC: Reexpansion pulmonary edema. Ann Thorac Surg 1988, 45:340-345.
54. Critchley LAH, Au HKA, Yim APC: Reexpansion pulmonary edema occurring after thoracoscopic drainage of a pleural effusion. J Clin Anesth 1996, 8:591-594. Case report and analysis of the possible mechanisms leading to this complication of reexpansion pulmonary edema, especially the rapid lung reexpansion seen after several weeks of collapse.
55. Nakamura H, Ishizaka A, Sawafuji M, Urano T, Fujishima S, Sakamaki F Sayama K, Kawamura M, Kato R, Kikuchi K, et al.: Elevated levels of interleukin-8 and leukotriene B4 in pulmonary edema fluid of a patient with reexpansion pulmonary edema. Am J Respir Crit Care Med 1994, 149:1037-1040.
56. Rinaldo JE, Owens GR, Rogers RM: Adult respiratory distress syndrome following intrapleural instillation of talc. J Thorac Cardiovasc Surg 1983, 85:523-526.
57. Bouchama A, Chastre J, Gaudichet A, Soler P, Gibert C: Acute pneumonitis with bilateral pleural effusion after talc pleurodesis. Chest 1984, 86:795-797.
58. Kennedy L, Harley RA, Sahn SA, Strange C: Talc slurry pleurodesis: pleural fluid and histologic analysis. Chest 1995, 107:1707-1712. From this experimental study done in rabbits, the authors report finding talc particles in distant organs after talc slurry pleurodesis. They also give a detailed description of the microscopic phenomena that take place after talc instillation.
59. Campos Werebe E, Milanez JRC, Saldiva PHN, Vargas FS, Ferreira DHR, Pazetti R, Pêgo-Fernandes PM, Jatene FB: Talc distribution by histologic analysis, after slurry pleurodesis using a rat model [abstract]. Chest 1996, 110(4 suppl):53S.
60. Campos JRM, Cohen RG, Dresler CM, Wetstein L, LoCicero J III, Rapo SE, Schwartz SM: Talc pleurodesis: talc slurry versus thoracoscopic insufflation in a porcine model. Discussion. Ann Thorac Surg 1996, 62:1003-1004.
61. Agrenius V, Chmielewska J, Widström O, Blombäck M: Increased coagulation activity of the pleura after tube drainage and quinacrine instillation in malignant pleural effusion. Eur Respir J 1991, 4:1135-1139.
62. Agrenius V, Chmielewska J, Widström O, Blombäck M: Pleural fibrinolytic activity is decreased in inflammation as demonstrated in quinacrine pleurodesis treatment of malignant pleural effusion. Am Rev Respir Dis 1989, 140:1381-1385.
63. Rodriguez-Panadero F, Segado A, Martin Juan J, Ayerbe R, Torres Garcia I, Castillo J: Failure of talc pleurodesis is associated with increased pleural fibrinolysis. Am J Respir Crit Care Med 1995, 151:785-790. This study reports on the role that regulation of pleural fibrinolytic activity plays in the outcome of talc pleurodesis.
64. Rodriguez-Panadero F, Segado A, Torres I, Martin J, Sanchez J, Castillo J: Thoracoscopy and talc poudrage induce an activation of the systemic coagulation system [abstract]. Am J Respir Crit Care Med 1995, 151:A357.
65. Rodriguez Panadero F, Segado A, Martin Juan J, Sanchez JF, Calderon E, Castillo J: Activation of systemic coagulation in talc poudrage can be (partially) controlled with prophylactic heparin [abstract]. Am J Respir Crit Care Med 1996, 153:A458.